Ratheesh Greeshma, Venugopal Jayarama Reddy, Chinappan Amutha, Ezhilarasu Hariharan, Sadiq Asif, Ramakrishna Seeram
Center for Nanofibers & Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Singapore 117576.
Science and Engineering Faculty, Queensland University of Technology, Brisbane, Australia.
ACS Biomater Sci Eng. 2017 Jul 10;3(7):1175-1194. doi: 10.1021/acsbiomaterials.6b00370. Epub 2017 Jan 5.
Recent advances in bioprinting technology have been used to precisely dispense cell-laden biomaterials for the construction of complex 3D functional living tissues or artificial organs. Organ printing and biofabrication provides great potential for the freeform fabrication of 3D living organs using cellular spheroids, biocomposite nanofibers, or bioinks as building blocks for regenerative therapy. Vascularization is often identified as a main technological barrier for building 3D organs in tissue engineering. 3D printing of living tissues starts with potential support of biomaterials to maintain structural integrity and degradation of certain time periods after printing of the scaffolds. Biofabrication is the production of complex living and nonliving biological products from raw materials such as cells, molecules, ECM, and biomaterials. Generally, two basic methods are used for the fabrication of scaffolds such as conventional/traditional fabrication processes and advance fabrication processes for engineering organs. A wide range of polymers and biomaterials are used for the fabrication of scaffolds in tissue engineering applications. 3D additive manufacturing is advancing day-by-day; however, there are various critical challenging factors used for fabricating 3D scaffolds. This review is aimed at understanding the various scaffold fabrication techniques, types of polymers and biomaterials used for the fabrication processes, various fields of applications, and different challenges faced in their fabrication of scaffolds in regenerative therapy.
生物打印技术的最新进展已被用于精确地分配载有细胞的生物材料,以构建复杂的三维功能性活组织或人造器官。器官打印和生物制造为使用细胞球体、生物复合纳米纤维或生物墨水作为再生治疗的构建模块自由形式制造三维活体器官提供了巨大潜力。血管化通常被认为是组织工程中构建三维器官的主要技术障碍。活组织的三维打印始于生物材料的潜在支撑,以维持结构完整性以及支架打印后特定时间段内的降解。生物制造是利用细胞、分子、细胞外基质和生物材料等原材料生产复杂的生物和非生物产品。一般来说,有两种基本方法用于制造支架,如传统制造工艺和用于工程器官的先进制造工艺。在组织工程应用中,广泛的聚合物和生物材料被用于制造支架。三维增材制造正在日益发展;然而,制造三维支架存在各种关键的挑战因素。这篇综述旨在了解各种支架制造技术、用于制造过程的聚合物和生物材料类型、各种应用领域以及在再生治疗中制造支架所面临的不同挑战。